Business news
121 stories · latest 06 Oct 2026 · clear filter
After a week with one small new issue, October's fundraising depends almost entirely on Jio Platforms, whose reported size is about twenty times that of Paras Healthcare. In Tonbo Imaging's case all proceeds go to…
Crude below $100 eases the import bill and the input costs of oil marketers, airlines, paints and chemicals, which is why Reliance, IndiGo and Asian Paints were among the gainers. Banks and consumer names moved on…
Two listed groups sit on either side of this. Health and general insurers would pay out less per claim, which is the industry's stated aim: it blames hospital billing inflation for rising claim costs and premiums…
The rebound was narrow: FMCG, consumer durables and PSU banks carried it, while small caps, hospitals and part of IT closed lower. ITC's move followed analyst comments that its response to the cigarette tax increase is…
The US is the largest export market for several listed Indian sectors: garments and home textiles, generic drugs, auto components, speciality chemicals, and gems and jewellery. For them the deal decides the tariff they…
A listing would give Indian investors a large pure industrial-gases company alongside Linde India, and a public valuation for a business that sells oxygen, nitrogen, hydrogen and speciality gases to steel mills…
The US is the largest single export market for Indian drugmakers. Most of what they ship there is generics, and the Commerce Department said generics and their ingredients fall outside the Section 232 tariff. That…
Promoter-group sales add free float and near-term supply in UltraTech shares, but heavy mutual fund buying shows domestic institutions absorbing it, and the stake sold is a small part of the promoter group's holding…
A weaker rupee raises the cost of crude, LNG, fertiliser, electronics and other imports, adding to inflation and squeezing companies that buy in dollars and sell at home, such as fuel retailers, airlines and…
The purchase roughly doubles Sun Pharma's revenue base and deepens its exposure to the US and biosimilars, but it is financed largely with $9.25-9.75 billion of new borrowing, so integration, synergy delivery and debt…